AML Incubator (AMLI) is a Canadian compliance advisory firm supporting fintechs, MSBs, payment providers, and payments and financial platforms with AML program design, remediation, and regulatory ...
CERo Therapeutics received FDA approval for its IND CMC amendment, crucial for starting CER-1236 patient dosing. The phase 1 trial will assess CER-1236's safety and efficacy in relapsed or refractory ...
The Bank Secrecy Act (BSA) and Anti-Money Laundering (AML) regulations are fundamental components of the financial industry’s efforts to combat financial crimes. As a BSA/AML Officer, it is crucial to ...
AML Best Practices for Private Fund Managers: The Prudence of Establishing an AML Compliance Program
Notwithstanding the foregoing, as a good business practice and to align with industry standards, Advisers are increasingly implementing for themselves and their Private Funds limited anti-money ...
AML Incubator (AMLI) today announced the launch of its Audit-Ready AML Readiness Program, a structured remediation and implementation ...
Revuforj, a menin inhibitor, is under priority review for relapsed or refractory mutant NPM1 AML, with a target action date of October 25, 2025. The AUGMENT-101 trial demonstrated Revuforj's efficacy, ...
The new service helps teams assess U.S. registration obligations and build audit-ready AML controls for partner and regulator ...
Anthracycline and cytarabine chemotherapy has been the backbone of induction chemotherapy for AML for more than 50 years. Advances in our understanding of leukemia biology and the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results